Exacerbation of carpal tunnel syndrome under treatment with valdecoxib.
Ruppen
Wilhelm
W
Institute of Anaesthesia; Kantonsspital; Lucerne, Switzerland; wruppen@freesurf.ch.
Schüpfer
Guido Karl
GK
D000328:Adult; D002349:Carpal Tunnel Syndrome / Q000150:complications*; D003288:Contusions / Q000601:surgery; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004487:Edema / Q000139:chemically induced; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects*; D007718:Knee Injuries / Q000601:surgery; D008297:Male; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases; D013449:Sulfonamides / Q000009:adverse effects*; D000096926:Benzenesulfonamides
D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007555:Isoxazoles; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases; D013449:Sulfonamides; C406224:valdecoxib; D000096926:Benzenesulfonamides; C496540:PTGS2 protein, human